Literature DB >> 24913074

Post liver transplant presentation of needle-track metastasis of hepatocellular carcinoma following percutaneous liver biopsy.

Daniel Joyce1, Gavin A Falk1, Namita Gandhi2, Koji Hashimoto3.   

Abstract

Hepatocellular carcinoma (HCC) is one of the few malignant tumours often treated without prior histological confirmation (in the patient with cirrhosis). Contrast-enhanced cross-sectional imaging is frequently diagnostic of HCC with a high degree of accuracy. However, on occasion, a liver biopsy is required, a complication of which can be needle-track metastasis. We present the case of a 57-year-old man who had previously undergone a liver transplant; he was found to have abdominal wall metastasis at the site of a prior percutaneous biopsy. This is the second case until now date of needle-track metastasis that presented following liver transplantation. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24913074      PMCID: PMC4054260          DOI: 10.1136/bcr-2013-010076

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Needle track seeding following percutaneous procedures for hepatocellular carcinoma.

Authors:  Giuseppe Cabibbo; Antonio Craxì
Journal:  World J Hepatol       Date:  2009-10-31

3.  Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study.

Authors:  Alessandro Grasso; Rosa Stigliano; Filomena Morisco; Hugo Martines; Alberto Quaglia; Amar P Dhillon; David Patch; Brian R Davidson; Keith Rolles; Andrew K Burroughs
Journal:  Transplantation       Date:  2006-06-15       Impact factor: 4.939

4.  Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma--a study based on 420 patients.

Authors:  G T Huang; J C Sheu; P M Yang; H S Lee; T H Wang; D S Chen
Journal:  J Hepatol       Date:  1996-09       Impact factor: 25.083

5.  [Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma. A study of 150 patients].

Authors:  C Chapoutot; P Perney; D Fabre; P Taourel; J M Bruel; D Larrey; J Domergue; A J Ciurana; F Blanc
Journal:  Gastroenterol Clin Biol       Date:  1999-05

6.  Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis.

Authors:  Riccardo Iannaccone; Andrea Laghi; Carlo Catalano; Plinio Rossi; Filippo Mangiapane; Takamichi Murakami; Masatoshi Hori; Francesca Piacentini; Italo Nofroni; Roberto Passariello
Journal:  Radiology       Date:  2005-02       Impact factor: 11.105

7.  The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.

Authors:  Angelo Sangiovanni; Matteo A Manini; Massimo Iavarone; Raffaella Romeo; Laura V Forzenigo; Mirella Fraquelli; Sara Massironi; Cristina Della Corte; Guido Ronchi; Maria Grazia Rumi; Piero Biondetti; Massimo Colombo
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

8.  Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD.

Authors:  Paul H Hayashi; James F Trotter; Lisa Forman; Marcelo Kugelmas; Tracy Steinberg; Paul Russ; Michael Wachs; Thomas Bak; Igal Kam; Gregory T Everson
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

Review 9.  Complications of percutaneous abdominal fine-needle biopsy. Review.

Authors:  E H Smith
Journal:  Radiology       Date:  1991-01       Impact factor: 11.105

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.